Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘25 |
|
|---|---|---|---|---|---|
| $3.52M | $4.67M | $1.15M | 23.6% |
|
|
| $3.51M | $3.87M | $356K | 37% |
|
|
| $3.5M | $10.2M | $6.7M | 59.8% |
|
|
304
KalVista Pharmaceuticals
KALV
$1.43B
| $3.5M | $14.1M | $10.6M | 120% |
|
| $3.5M | $4.84M | $1.34M | 12.6% |
|
|
| $3.5M | $4.15M | $645K | 2.56% |
|
|
| $3.46M | $4.75M | $1.29M | 35.5% |
|
|
| $3.44M | $3.55M | $108K | 17.2% |
|
|
| $3.36M | $5.28M | $1.93M | 92.9% |
|
|
| $3.34M | $3.42M | $82K | 30.4% |
|
|
311
Lexicon Pharmaceuticals
LXRX
$964M
| $3.33M | $3.78M | $450K | 60.7% |
|
| $3.28M | $12M | $8.75M | 73% |
|
|
| $3.27M | $3.66M | $385K | 71.6% |
|
|
| $3.24M | $3.79M | $556K | 54.1% |
|
|
| $3.23M | $7M | $3.76M | 116% |
|
|
| $3.22M | $3.44M | $216K | 22% |
|
|
| $3.2M | $3.25M | $49K | 34.4% |
|
|
| $3.19M | $3.33M | $139K | 47.6% |
|
|
| $3.19M | $3.46M | $270K | 38.8% |
|
|
| $3.15M | $11.4M | $8.24M | 30.5% |
|
|
| $3.14M | $3.96M | $827K | 79.7% |
|
|
| $3.13M | $7.19M | $4.06M | 4.03% |
|
|
| $3.13M | $3.19M | $63K | 49.8% |
|
|
| $3.1M | $3.51M | $408K | 32.3% |
|
|
| $3.1M | $3.88M | $782K | 24.1% |
|